(Reuters) – Novavax Inc said on Wednesday it has signed an agreement with the Australian Government to supply 40 million doses of the its COVID-19 vaccine candidate, NVX-CoV2373.
Under the agreement, the company will deliver its vaccine to Australia starting as early as the first half of 2021, Novavax said.
The company added it expects to report late-stage data from its UK trial as soon as the first quarter of 2021.
(Reporting by Dania Nadeem in Bengaluru; Editing by Aditya Soni)
